title: [Radiation pneumonitis and pulmonary fibrosis after the CT-planned radiotherapy of bronchial carcinoma].
abstract: OBJECTIVE
  Examination of the influence of total tumor dose, additional therapy and age on the development of radiation pneumonitis and lung fibrosis.
  
  
  METHODS
  Two hundred and sixteen patients with squamous cell carcinoma of the lung were examined retrospectively. Hundred and eighty-three of them received a percutaneous radiation therapy of the primary tumor and the mediastinal and ipsilateral hilar lymph nodes. The majority of 130 patients was given radiotherapy as only treatment, 27 were irradiated after resection and 26 received chemo- and radiotherapy. Treatment volume was determined by three-dimensional planning using chest CT-scan. The irradiation was administered in a first series of 56 Gy and a following boost to the primary and involved lymph nodes to a total dose of 70 Gy. There was one daily irradiation with 2 Gy 5 days a week. Post-resectional radiation encompassed the bronchus stump and the mediastinum with a total dose of about 60 Gy.
  
  
  RESULTS
  Sixty-eight of the 183 irradiated patients developed a pneumonitis (37.2%) and 60 a lung fibrosis (32.8%). The most important factor was the administered total irradiation dose (p < 0.001). There was no pneumonitis documented below 36 Gy and no fibrosis below 40 Gy. An additional chemotherapy did not increase the incidence (pneumonitis after radiotherapy 35.4%, after radio- and chemotherapy 34.6%; fibrosis after radiotherapy 33.9%, after radio- and chemotherapy 38.5%). Particularly high was the incidence of pneumonitis when radiotherapy followed resection (48.2%) while the rate of fibrosis in this group of patients was relatively low (22.2%). Age of patients did not affect the frequency of pneumonitis while fibrosis significantly occurred more often with increasing age (p = 0.037).
  
  
  CONCLUSIONS
  The total dose affecting the normal lung tissue is the most important factor for the development of radiation pneumonitis and lung fibrosis. It is recommended to keep the treatment volume appropriate to the individual extend of tumor. Good results are achieved with a computer supported CT-planning which helps to gain minimal burdening of normal tissue.
authors.affiliation: Klinik für Strahlentherapie, Universität Würzburg.
authors.forename: G
authors.initials: G
authors.lastname: Müller
authors.forename: I C
authors.initials: IC
authors.lastname: Kiricuta
authors.forename: J
authors.initials: J
authors.lastname: Stiess
authors.forename: W
authors.initials: W
authors.lastname: Bohndorf
mesh_terms: D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D002283:Carcinoma, Bronchogenic / Q000150:complications / Q000000981:diagnostic imaging / Q000401:mortality / Q000532:radiotherapy*; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000000981:diagnostic imaging / Q000401:mortality / Q000532:radiotherapy*; D005260:Female; D005860:Germany, West / Q000453:epidemiology; D006801:Humans; D008175:Lung Neoplasms / Q000150:complications / Q000000981:diagnostic imaging / Q000401:mortality / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D010347:Patient Care Planning; D011658:Pulmonary Fibrosis / Q000453:epidemiology / Q000209:etiology*; D017564:Radiation Pneumonitis / Q000453:epidemiology / Q000209:etiology*; D011879:Radiotherapy Dosage; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed
vernacular_title: Strahlenpneumonitis und Lungenfibrose nach CT-geplanter Radiotherapie des Bronchialkarzinoms.